Skip to main content

An ongoing commitment.

An ongoing commitment.

With over 30 years of research and clinical experience, Novo Nordisk has a continuing commitment to people living with hemophilia and the bleeding disorders community. We believe that the keys to lasting success is to stay focused, think longterm, and do business in a financially, socially, and environmentally responsible way.

Product portfolio.

We aspire to be a respected leader in the health care industry, helping patients with treatments for:


FVII deficiency


FVIII deficiency


FVIII deficiency with inhibitors


FIX deficiency


FIX deficiency with inhibitors


FXIII deficiency


Glanzmann’s thrombasthenia


Acquired hemophilia


Environmental awareness.

We also strive to minimize the environmental impact of our activities. Our facilities in Denmark supply quality products in a socially responsible and environmentally sound way, using 100% renewable energy.

Research and development.

Novo Nordisk is committed to investing in Research and Development. In 2013, 14% of sales went toward funding R&D projects across the organization.

An ongoing commitment.

With over 30 years of research and clinical experience, Novo Nordisk has a continuing commitment to people living with hemophilia and the bleeding disorders community. We believe that the keys to lasting success is to stay focused, think longterm, and do business in a financially, socially, and environmentally responsible way.

Product portfolio.

We aspire to be a respected leader in the health care industry, helping patients with treatments for:

FVII deficiency


FVIII deficiency


FVIII deficiency with inhibitors


FIX deficiency


FIX deficiency with inhibitors


FXIII deficiency


Glanzmann’s thrombasthenia


Acquired hemophilia


Environmental awareness.

We also strive to minimize the environmental impact of our activities. Our facilities in Denmark supply quality products in a socially responsible and environmentally sound way, using 100% renewable energy.

Research and development.

Novo Nordisk is committed to investing in Research and Development. In 2013, 14% of sales went toward funding R&D projects across the organization.

The Triple Bottom Line.

The Triple Bottom Line (TBL) is Novo Nordisk’s way of doing business. We believe that a healthy economy, environment, and society are fundamental to long-term business success. We are one of only 4 companies in the world who have incorporated our philosophy into our company bylaws.


Everything we do and every decision we make is informed by the three pillars of TBL:

Social impact.
Social responsibility is about caring for people. This applies to the people who depend on our products, as well as to our employees. We work to continuously integrate social, health, and safety considerations into our daily business.

Environmental responsibility.
Environmental soundness addresses our impact on the external environment—and we've taken a concerted approach to ensure that our efforts to be green pay off.

Our LEED Silver certified U.S. Headquarters demonstrates our approach to being responsible stewards of our environment. Our campus utilized recycled and locally-sourced materials, and is fully powered by renewable energy from wind, solar, and hydro sources—a feature that is expected to lead to a 30 percent reduction in energy costs.

Financial performance.
Economic viability is about managing the business in a way that secures growth and value creation, and delivers competitive performance in these areas. Investing in our employees contributes to our award-winning workplace and supports our goal of delivering innovative achievements.

Novo Nordisk Inc. has been ranked in Fortune Magazine's Best Places to Work listing every year since 2009. Most recently, Novo Nordisk was presented with the New Good Neighbor Award by the New Jersey Business & Industry Association. This award was based on a variety of factors, including economic benefit/job creation, architectural merit, and community involvement.

The Triple Bottom Line.

The Triple Bottom Line (TBL) is Novo Nordisk’s way of doing business. We believe that a healthy economy, environment, and society are fundamental to long-term business success. We are one of only 4 companies in the world who have incorporated our philosophy into our company bylaws.


Everything we do and every decision we make is informed by the three pillars of TBL:

Social impact.
Social responsibility is about caring for people. This applies to the people who depend on our products, as well as to our employees. We work to continuously integrate social, health, and safety considerations into our daily business.

Environmental responsibility.
Environmental soundness addresses our impact on the external environment—and we've taken a concerted approach to ensure that our efforts to be green pay off.

Our LEED Silver certified U.S. Headquarters demonstrates our approach to being responsible stewards of our environment. Our campus utilized recycled and locally-sourced materials, and is fully powered by renewable energy from wind, solar, and hydro sources—a feature that is expected to lead to a 30 percent reduction in energy costs.

Financial performance.
Economic viability is about managing the business in a way that secures growth and value creation, and delivers competitive performance in these areas. Investing in our employees contributes to our award-winning workplace and supports our goal of delivering innovative achievements.

Novo Nordisk Inc. has been ranked in Fortune Magazine's Best Places to Work listing every year since 2009. Most recently, Novo Nordisk was presented with the New Good Neighbor Award by the New Jersey Business & Industry Association. This award was based on a variety of factors, including economic benefit/job creation, architectural merit, and community involvement.

Stay updated with news and information from Novo Nordisk.


Get tips on managing your bleeding disorder.


Learn more about hemophilia treatments.


Stay informed about patient support services.


Find out about educational workshops and events.


Stay updated with news and information from Novo Nordisk.


Get tips on managing your bleeding disorder.


Learn more about hemophilia treatments.


Stay informed about patient support services.


Find out about educational workshops and events.